CRISPLD2在系统性硬化症皮肤纤维化中的作用及机制
本研究通过生物信息学筛选TGF-β通路相关基因,并在体内外验证系统性硬化症表型,结合转录组测序探讨分子机制。结果发现人富半胱氨酸分泌蛋白LCCL结构域蛋白2(CRISPLD2)在TGF-β诱导的成纤维细胞中反应性增高,且CRISPLD2上调时ACTA2(α-SMA)表达显著降低。结论认为CRISPLD2以负反馈调节方式参与TGF-β诱导的成纤维细胞纤维化。
要点
- CRISPLD2在TGF-β诱导的成纤维细胞中反应性增高。
- CRISPLD2上调时TGF-β介导的成纤维细胞中ACTA2(α-SMA)表达显著降低。
- CRISPLD2以负反馈调节方式参与TGF-β诱导的成纤维细胞纤维化。
核心结论
- CRISPLD2在TGF-β诱导的成纤维细胞中反应性增高,并以负反馈调节方式参与TGF-β诱导的成纤维细胞纤维化。
研究设计与样本
- 通过生物信息学分析筛选TGF-β通路相关基因,并在体内和体外验证系统性硬化症表型,结合转录组测序初步探讨相关分子机制。
主要发现
- 人富半胱氨酸分泌蛋白LCCL结构域蛋白2(CRISPLD2)在TGF-β诱导的成纤维细胞中反应性增高。
- 在TGF-β介导的成纤维细胞中,CRISPLD2上调时ACTA2(α-SMA)表达显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: SSc is an autoimmune connective tissue disease involving multiple organs. The most common clinical symptom of SSc is progressive fibrosis of the skin, and the pathologically manifestations of skin were activation and proliferation of fibroblasts and continuous proliferation of extracellular matrix. TGF-β can promote the proliferation and activation of fibroblasts, causing excessive deposition of collagen and structural proteins. Therefore, exploring the specific mechanism of TGF-β-related pathway on fibrosis is of great significance for improving skin fibrosis in SSc. METHODS: Genes related to TGF-β pathway were screened through bioinformatics analysis, and SSc phenotypes were verified in vivo and in vitro. The relevant molecular mechanisms were preliminarily discussed in combination with transcriptome sequencing. RESULTS: Human cysteine-rich secreted protein LCCL domain protein 2 (CRISPLD2) was found increased reactivity in TGF-β-induced fibroblasts, and the expression of ACTA2 (ɑ-SMA) decreased significantly in TGF-β-mediated fibroblasts with up-regulation of CRISPLD2. CONCLUSION: CRISPLD2 was found to have increased reactivity in TGF-β-induced fibroblasts, and we further confirmed that CRISPLD2 can participate in TGF-β-induced fibroblast fibrosis from multiple perspectives and levels in negative feedback regulation, and investigated the mechanism of CRISPLD2 in fibrosis.
引用
- Ding L, Bao D, Dai B, et al. The role and mechanism of CRISPLD2 in skin fibrosis of systemic sclerosis. Rheumatology (Oxford). 2025. PMID: 39374552. doi:10.1093/rheumatology/keae541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。